Association of serum interleukin-17 level with early recurrence and prognosis after radical surgery in hepatocellular carcinoma patients with different levels of alpha-fetoprotein

Deng WeiWei; Zhu WenMing; Yi Chao; Feng YangChun; Huang YanChun

doi:10.3969/j.issn.1001-5256.2018.02.016

Issue 2

Feb. 2018

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2018 > 34(2): 298-302

PDF( 263 KB)

Association of serum interleukin-17 level with early recurrence and prognosis after radical surgery in hepatocellular carcinoma patients with different levels of alpha-fetoprotein

DOI: 10.3969/j.issn.1001-5256.2018.02.016

Department of Clinical Laboratory, The Affiliated Tumor Hospital of Xinjiang Medical University

Research funding:

Published Date: 2018-02-20

Abstract

Abstract

Objective To investigate the expression of interleukin-17 (IL-17) in hepatitis B virus (HBV) -related hepatocellular carcinoma (HCC) with different levels of alpha-fetoprotein (AFP) , as well as its association with recurrence and prognosis after radical treatment for HCC.Methods A total of 167 patients with HBV-related HCC who underwent radical resection in The Affiliated Tumor Hospital of Xinjiang Medical University from January 2013 to December 2014 were enrolled, and 115 patients with hepatic hemangioma (including 83 HBV carriers) were enrolled as control group.ELISA was used to measure the serum level of IL-17 in 167 patients with HBV-related HCC, and electrochemical luminescence was used to measure the serum level of AFP.The correlation between the expression of IL-17 and the serum level of AFP was analyzed, as well as the association of the expression of IL-17 with recurrence and survival after radical resection of HCC.The chi-square test was used for comparison of categorical data between groups, and the Kaplan-Meier method, log-rank test, and Cox proportional hazards model were used for survival analysis.Results The patients with HBV-related HCC were divided into two groups according to the serum level of AFP, and there was a significant difference in the positive expression rate of IL-17 between AFP <400 ng/ml group and AFP≥400 ng/ml group [50.9% (58/114) vs 34.0% (18/53) , χ2= 8.11, P = 0.002]; there were also significant differences between these two groups in disease-free survival (34.1 months vs 13.4 months, χ2= 10.34, P < 0.05) , overall survival (84.2 months vs 57.4 months, χ2= 3.13, P < 0.05) , and tumor recurrence rate within 1 year (28.9% vs 50.9%, χ2= 10.89, P <0.05) .The Kaplan-Meier analysis showed that among the patients with HBV-related HCC and AFP < 400 ng/ml, the patients with positive expression of IL-17 had a significantly higher recurrence rate within 1 year after surgery than those with negative expression of IL-17, as well as significantly shorter disease-free survival and overall survival than those with low expression of IL-17 (χ2= 7.350, 3.814, and9.744, all P < 0.05) .The Cox proportional hazards model showed that positive expression of IL-17, tumor thrombus in vessels, and degree of tumor differentiation were influencing factors for the prognosis of HCC patients (all P < 0.05) .Conclusion For patients with HBV-related HCC and AFP < 400 ng/ml, positive expression of IL-17 indicates early recurrence and poor prognosis.
- cacinoma, hepatocellular,
- alpha-fetoprotein,
- interleukin-17,
- prognosis

FullText(HTML)

References(19)

References

[1]SUKOWATI GH, EL-KHOBA KE, LE SI, et al.Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoa[J].World J Gastroenterol, 2016, 22 (4) :1497-1512.

[2]LIU XH, ZHAO YM, ZHAO XF, et al.Diagnostic and therapeutic progress on hepatocellular carcinoma[J/CD].Chin J Liver Dis:Electronic Edition, 2017, 9 (2) :20-25. (in Chinese) 刘秀红, 赵一鸣, 赵晓飞, 等.肝细胞癌诊断与治疗研究进展[J/CD].中国肝脏病杂志:电子版, 2017, 9 (2) :20-25.

[3]GEOFFREY J, MARKKOWITZ, GREGORY A, et al.Inflammatory models drastically alter tumor growth and the immune microenvironment in hepatocellular carcinoma[J].Sci Bull (Beijing) , 2015, 60 (8) :762-772.

[4]SOLINI M, KIRILOVSKY A, MLECNIK B, et al.Clinical impact of different glasses of infiltrating T cytotoxic and helper cells (Thl, th2, treg, thl7) in patients with colorectal cancer[J].Cancer Res, 2011, 71 (4) :1263-1271.

[5]STOCKINGER B, VELDHOEN M, MARTIN B, et al.Th17 T cells:linking innate andadaptive irnmunity[J].Semin Immunol, 2007, 19 (6) :353-361.

[6]EDGE SB, BYRD DR, COMPTON CC, et al.AJCC Cancer Staging Manual[M].7th ed.New York:Springer-Verlag, 2010.

[7]LANAYA H, NATARAJAN A, KOMPOSCH K, et al.EGFR has a tumourpromoting role in liver macrohages during hepatocellular carcinoma formation[J].Nat Cell Biol, 2014, 16 (10) :972-977.

[8]BERTINO G, ARDIRI A, MALAGUARNERA M, et al.Hepatocellualar carcinonm serunl markers[J].Semin Oncol, 2012, 39 (4) :410-433.

[9]YAMAMOTO K, IMAMURA H, MATSUYAMA Y, et al.AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC[J].J Gastroenterol, 2010, 45 (12) :1272-1282.

[10]COLLI A, FRAQUELLI M, CASAZZA G, et al.Accuracy of ultrasonography, spiral CT, mag-netic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma:a systematic review[J].J Gastroenterol, 2006, 101 (3) :513-523.

[11]GAMBARIN-GELWAN M, WOLF DC, SHAPIRO R, et al.Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in hepatitis C virus cirrhosis[J].Hepatology, 2000, 95 (6) :1535-1538.

[12]LI JY, SONG JY, WANG JF, et al.Value of combined detection of AFP, CA19-9, CEA in early diagnosis of primary liver cancer[J].J Clin Hepatol, 2017, 33 (7) :1291-1295. (in Chinese) 李嘉妍, 宋金云, 王建芳, 等.AFP、CA19-9、CEA联合检测对原发性肝癌的早期诊断价值[J].临床肝胆病杂志, 2017, 33 (7) :1291-1295.

[13]BAE JS, PARK SJ, PARK KB, et al.Acute exacerbation of hepatitis in liver cirrhosis with very high levels of alpha-fetoprotein but no occurrence of hepatocellular carcinoma[J].Korean J Intern Med, 2005, 20 (1) :80-85.

[14]MA WJ, WANG HY, TENG LS, et al.Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy[J].World J Surg Oncol, 2013, 11:212.

[15]TU JF, PAN HY, YING XH, et al.Mast cells comprise the major of interleukin 17-producing cells and predict a poor prognosis in hepatocellular carcinoma[J].Medicine (Baltimore) , 2016, 95 (13) :e3220.

[16]AZZAZENE D, AL THAWADI H, AL FARSI H, et al.Plasma endothelial protein C receptor influences innate immune response in ovarian cancer by decreasing the population of natural killer and TH-17 helper cells[J].Int J Oncol, 2013, 43 (4) :1011-1018.

[17]DU WJ, ZHEN JH, ZENG ZQ, et al.Expression of interleukin-17 associatedwith disease progression and liver fibrosis with hepatitis B virus infection:IL-17 in HBV infection[J].Diagn Pathol, 2013, 8:40.

[18]REDA R, ABBAS AA, MOHAMMED M, et al.The interplay between Zinc, Vitamin D and IL-17 in patients with chronic hepatitis C liver disease[J].J Immunol Res, 2015, 2015:846348.

[19]LLOSA NJ, GEIS AL, THIELE ORBERG E, et al.Interleukin-17 and type 17 helper T cells in cancer management and research[J].Immunotargets Ther, 2014, 3:39-54.

Relative Articles

[1]	Development Committee of Clinical Practice Guidelines for Robotic Hepatopancreatobiliary Surgery. Clinical practice guidelines for robotic hepatopancreatobiliary surgery[J]. Journal of Clinical Hepatology, 2019, 35(7): 1459-1471. doi: 10.3969/j.issn.1001-5256.2019.07.009
[2]	Development Committee of Clinical Practice Guidelines for Laparoscopic Hepatopancreatobiliary Surgery. Clinical practice guidelines for laparoscopic hepatopancreatobiliary surgery[J]. Journal of Clinical Hepatology, 2019, 35(7): 1450-1458. doi: 10.3969/j.issn.1001-5256.2019.07.008
[3]	Xu YanLing, Zhao Xu, Guo XiaoLin, Ji HuiFan, Zhang Ying, Song XinYue, Wang JingYu, Sun XiaoFeng, Liu Kai, He RongHua, Gao PuJun. Clonorchiasis complicated by multiple cholelithiasis and cholestatic cirrhosis misdiagnosed as Budd-Chiari syndrome: A case report[J]. Journal of Clinical Hepatology, 2018, 34(7): 1514-1516. doi: 10.3969/j.issn.1001-5256.2018.07.029
[4]	Zhao GuoPing, Hu JianPing, Wang JiRong. Clinical experience in choledochoscopy for the treatment of intrahepatic bile duct stones complicated by biliary stricture:a clinical analysis of 230 cases[J]. Journal of Clinical Hepatology, 2017, 33(11): 2166-2169. doi: 10.3969/j.issn.1001-5256.2017.11.023
[5]	Jiang Chao, Wang HaiJiu, Ren Li, Yang DanCaiRang, Hou LiChao, Zhou Ying, Wen Hao, Fan HaiNing. Application status of three- dimensional CT reconstruction in hepatobiliary surgery[J]. Journal of Clinical Hepatology, 2017, 33(2): 389-393. doi: 10.3969/j.issn.1001-5256.2017.02.041
[6]	Lu Xia, Jia HaiMing, Mi TaiYu, Zhang WenQuan, Gao Peng. Effect of fast track surgery on anxiety index and stress indices in patients undergoing laparoscopic cholecystectomy[J]. Journal of Clinical Hepatology, 2017, 33(2): 308-312. doi: 10.3969/j.issn.1001-5256.2017.02.022
[7]	Wu Xiao, Xia Hao, Wu Jian, Zhang Ming. Clinical experience in treatment of complex intrahepatic bile duct stones by regular hepatectomy[J]. Journal of Clinical Hepatology, 2016, 32(9): 1756-1759. doi: 10.3969/j.issn.1001-5256.2016.09.025
[8]	Wu ErBin, Zhang JinWei. Clinical application of selective intraoperative cholangiography in biliary system surgery[J]. Journal of Clinical Hepatology, 2016, 32(7): 1357-1359. doi: 10.3969/j.issn.1001-5256.2016.07.031
[9]	Chen ZhiYu, Bie Ping. Clinical application of combined vascular resection and reconstruction in surgical treatment of hilar cholangiocarcinoma[J]. Journal of Clinical Hepatology, 2016, 32(7): 1277-1279. doi: 10.3969/j.issn.1001-5256.2016.07.011
[10]	Han Wei, Yue Qing, Yan JingZhe, Jia BaoXing, Wang YingChao, Liu YaHui. Concept of fast-track surgery and its application in perioperative period of hepatectomy for liver cancer[J]. Journal of Clinical Hepatology, 2016, 32(10): 2007-2011. doi: 10.3969/j.issn.1001-5256.2016.10.044
[11]	Qi WenLei, Zhang RuoYan, Chai WenGang, Liu MingJiang, Du XiaoHong, Ye JunFeng. Diagnosis of clonorchiasis during and after biliary tract surgery: a clinical analysis of 15 cases[J]. Journal of Clinical Hepatology, 2016, 32(11): 2134-2137. doi: 10.3969/j.issn.1001-5256.2016.11.026
[12]	Cheng XiangChao, Yuan QiDong, Zhao JianHong, Liu Bin. Percutaneous transhepatic approach for intrahepatic and extrahepatic bile duct stones: a clinical analysis of 19 cases[J]. Journal of Clinical Hepatology, 2015, 31(10): 1685-1687. doi: 10.3969/j.issn.1001-5256.2015.10.031
[13]	Zhang HaoYu, Liu Bin. Research advances in surgical treatment of intrahepatic bile duct stones[J]. Journal of Clinical Hepatology, 2015, 31(10): 1726-1729. doi: 10.3969/j.issn.1001-5256.2015.10.046
[14]	Li QiNan, Zhang YuHuai, Geng Jie. Safety and efficacy of fast-track surgery in perioperative nursing for biliary calculi surgery: a meta-analysis[J]. Journal of Clinical Hepatology, 2015, 31(10): 1660-1664. doi: 10.3969/j.issn.1001-5256.2015.10.025
[15]	Xing TongChao, Ren Bin, Wang YuPeng, Yang DongXing. Clinical effect of choledochofiberscope-assisted secondary surgery in treatment of intrahepatic and extrahepatic biliary stones[J]. Journal of Clinical Hepatology, 2015, 31(8): 1325-1327. doi: 10.3969/j.issn.1001-5256.2015.08.036
[16]	Li Jiang, Liu Bin. More attention to initial surgical treatment of hepatolithiasis[J]. Journal of Clinical Hepatology, 2015, 31(10): 1612-1614. doi: 10.3969/j.issn.1001-5256.2015.10.012
[17]	Tang CaiXi, Zhao ZhiJian, Feng Bin, Yang KaiQing. Surgical treatment of cholangiolithiasis with cavernous transformation of the portal vein: a review and analysis of 18 cases[J]. Journal of Clinical Hepatology, 2014, 30(1): 39-41. doi: 10.3969/j.issn.1001-5256.2014.01.013
[18]	Lu: WenPing. Clinical classification of hepatolithiasis and choice of surgical strategy[J]. Journal of Clinical Hepatology, 2013, 29(6): 404-406+410.
[19]	Wu LiMing, Cheng CaiTao, Wang JiangHua, Chen XianXiang. Clinical effect of laparoscopic reoperation combined with choledochoscope in treatment of intra-and extrahepatic bile duct stones:analysis of 35 cases[J]. Journal of Clinical Hepatology, 2013, 29(7): 516-519. doi: 1001-5256 (2013) 07-0516-04
[20]	Ou Xi, Xiong Pei, Ye JianYu, Liu JiKui. Application of medical obturation glue in the treatment of hepatolithiasis with laparoscopic hepatectomy[J]. Journal of Clinical Hepatology, 2011, 27(9): 927-930.

Supplements(0)

Cited By

Cited by

Periodical cited type(13)

1.	路燕，陈明月，郑秀良，雷宇. 185例药物性肝损伤患者的临床特征分析. 安徽医学. 2022(03): 308-313 .
2.	赵临潇，左博云，李静亚，于东升. 妊娠期肝内胆汁淤积症孕妇胎盘ABCB4基因表达与妊娠结局的关系. 海南医学. 2022(11): 1424-1427 .
3.	张慧芳，王高莹，邹萍，王晶，董蕊锐，张婷，孟西娜. 妊娠期肝内胆汁淤积症血清甘胆酸水平与妊娠结局的关系. 中国临床研究. 2022(06): 793-796 .
4.	林洪萍，黄晋萍，黄淑兰，卢君，黎春，杨佳柳. 中药外洗在妊娠期肝内胆汁淤积症诱发皮肤瘙痒患者中的应用. 中国医学创新. 2022(19): 96-99 .
5.	李媛，郑泽玉，田阗，邬洪明，田嫣然，李茂. 妊娠期肝内胆汁淤积症的危险因素分析. 临床和实验医学杂志. 2021(02): 200-203 .
6.	段兴平，王燕，黄常友，郑会贤，罗一，覃正文，任郁. 妊娠期肝病的临床特征及研究进展. 临床肝胆病杂志. 2020(06): 1407-1411 . 本站查看
7.	陈韵洁，张晨，谭娟. 脂肪酸转运体蛋白FATP4、CD36、FABP1在妊娠期肝内胆汁淤积胎盘中表达研究. 中外医疗. 2020(15): 30-31+46 .
8.	唐照青，俞海珍. 联合监护评估对妊娠期无症状高胆汁酸血症孕妇围生儿预后的价值. 中国现代药物应用. 2020(18): 19-22 .
9.	汪学耀，张涛，荆成宝. 血清总胆汁酸与甘胆酸水平诊断妊娠期肝内胆汁淤积症能力的Meta分析. 现代检验医学杂志. 2020(05): 73-76 .
10.	吕玉清. 我院中药处方中妊娠患者疾病及用药情况分析研究. 海峡药学. 2020(10): 176-178 .
11.	刘燕，王丽娟，李盈盈. 综合护理在妊娠期肝内胆汁淤积症患者中的临床效果分析. 妇产与遗传(电子版). 2020(03): 40-44 .
12.	张燕，王伟红. 妊娠期肝内胆汁淤积症孕妇血清总胆汁酸、谷草转氨酶及Th17/Treg平衡水平及临床意义. 中国计划生育学杂志. 2020(12): 2093-2097 .
13.	马艳辉，邵久玲，王双梅. 低分子肝素治疗妊娠期肝内胆汁淤积症的疗效及对肝胆指标、母婴结局的影响. 哈尔滨医药. 2020(05): 438-440 .

Other cited types(3)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (442) PDF downloads(71)

Association of serum interleukin-17 level with early recurrence and prognosis after radical surgery in hepatocellular carcinoma patients with different levels of alpha-fetoprotein

DOI: 10.3969/j.issn.1001-5256.2018.02.016